Clinical trial
S90652 in Paediatric Hypertension
NCT00202553 · Institut de Recherches Internationales Servier, Other · Completed
Key facts
| NCT number | NCT00202553 |
|---|---|
| Title | S90652 in Paediatric Hypertension |
| Official title | Acceptability, Safety, Pharmacokinetics and Effects on Blood Pressure of a Daily Dose of 0.025 to 0.135 Milligram Per Kilogram of S90652, a Paediatric Formulation of Perindopril, in 2-16 Years Old Hypertensive Children - 3 Month Study |
| Lead sponsor | Institut de Recherches Internationales Servier, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Perindopril |
| Enrollment | 50 |
| Start date | Jul 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 11, 2018 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: